OCUPHIRE PHARMA INC. - COMMON STOCK
1.5800
21-June-24 14:59:52
15 minutes delayed
Stocks
-0.0200
-1.25%
Today's range
1.5450 - 1.6450
ISIN
N/A
Source
NASDAQ
-
06 Jun 2024 06:57:22 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2024 06:14:52 By Nasdaq GlobeNewswire
-
08 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Feb 2024 15:10:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 Jan 2024 15:10:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 Nov 2023 15:38:14 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 Nov 2023 07:00:01 By Nasdaq GlobeNewswire
-
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2023 15:52:46 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >